Charles Schwab Investment Management Inc. Increases Stake in Arvinas, Inc. (NASDAQ:ARVN)
Charles Schwab Investment Management Inc. lifted its stake in shares of Arvinas, Inc. (NASDAQ:ARVN – Free Report) by 1.0% during the 4th quarter, according to its most recent disclosure with the ...
Citi Sticks to Their Buy Rating for Alpha Tau Medical Ltd (DRTS)
Citi analyst Yigal Nochomovitz reiterated a Buy rating on Alpha Tau Medical Ltd (DRTS – Research Report) yesterday and set a price target of ...
Pfizer (NYSE:PFE) To Divest Entire 7 Percent Stake In Haleon Through Share Offering
Pfizer (NYSE:PFE) announced its intention to sell its entire residual shareholding in Haleon plc, reflecting a divestment ...
Down -54.85% in 4 Weeks, Here's Why Arvinas (ARVN) Looks Ripe for a Turnaround
Arvinas (ARVN) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising ...
PMLive4d
Pfizer/Arvinas’ vepdegestrant shows promise in phase 3 breast cancer study
The phase 3 VERITAC-2 trial has been evaluating the candidate against AstraZeneca’s endocrine therapy Faslodex (fulvestrant) ...
Is Arvinas, Inc. (ARVN) a Pump and Dump Stock Favored by Hedge Funds?
We recently compiled a list of the 10 Pump and Dump Stocks Favored by Hedge Funds. In this article, we are going to take a ...
Wedbush Issues Positive Outlook for Arvinas Earnings
Analysts at Wedbush raised their Q1 2025 earnings per share (EPS) estimates for Arvinas in a report issued on Wednesday, ...
Inozyme Pharma (INZY) Gets a Buy from Bank of America Securities
In a report released today, Tazeen Ahmad from Bank of America Securities reiterated a Buy rating on Inozyme Pharma (INZY – Research Report), ...